《美股業績》Tesla(TSLA.US)季績勝預期 料今年交付量增長逾50%
Tesla(TSLA.US)第四季盈利增長7.6倍至23.2億美元,每股盈利爲2.52美元,高於預期的2.36美元。收入增長65%至177.2億美元,優於市場預期的165.7億美元。
行政總裁馬斯克表示,預計Tesla今年仍然面對晶片不足的問題,供應鏈中斷將持續到今年,因此公司今年不會推出任何新車型,但預計全年交付量仍將按年增長超過50%,Cybertruck、Semi及Roadster等新車型則留待明年推出。
Tesla表示,位於德州奧斯汀的新工廠已於去年底開始生產Model Y,計劃汽車得到最終認證後將開始向客戶交付。同時公司目標將加州廠房產量最大化,計劃每年生產超過60萬輛電動車。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.